| human | Q5 |
| P6178 | Dimensions author ID | 01321420010.27 |
| P244 | Library of Congress authority ID | n2014182304 |
| P8189 | National Library of Israel J9U ID | 987007364820505171 |
| P496 | ORCID iD | 0000-0002-4663-7985 |
| P1153 | Scopus author ID | 7006141993 |
| P10861 | Springer Nature person ID | 01321420010.27 |
| P214 | VIAF ID | 307434965 |
| P10832 | WorldCat Entities ID | E39PBJjHfyBwQf9k6d3xyp9VYP |
| P734 | family name | Judson | Q16290335 |
| Judson | Q16290335 | ||
| Judson | Q16290335 | ||
| P735 | given name | Marc | Q17520944 |
| Marc | Q17520944 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q45378538 | A conceptual model of health-related quality of life in sarcoidosis |
| Q24609077 | A concise review of pulmonary sarcoidosis |
| Q73408703 | A current assessment of rurally linked exposures as potential risk factors for sarcoidosis |
| Q39526956 | A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma |
| Q80866568 | A neutropenic patient with rapidly progressive lung lesion |
| Q46652447 | A new tool to assess sarcoidosis severity |
| Q79362317 | A proposed solution to the clinical assessment of sarcoidosis: the sarcoidosis three-dimensional assessment instrument (STAI) |
| Q42621528 | A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis |
| Q77926196 | Airway obstruction arising from blood clot: three reports and a review of the literature |
| Q28267560 | Allergic bronchopulmonary aspergillosis |
| Q46023293 | Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: a potential mechanism related to T-helper cytokine balance. |
| Q28207287 | Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference |
| Q77339548 | An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment |
| Q60153711 | COMPLICATIONS OF VIDEO ASSISTED THORACOSCOPIC LUNG BIOPSY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE |
| Q82961419 | Cardiac sarcoidosis |
| Q44797509 | Cardiac sarcoidosis: there is no instant replay |
| Q37333443 | Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis |
| Q38382157 | Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. |
| Q36845759 | Chronic cutaneous lesions of sarcoidosis. |
| Q46232692 | Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems |
| Q37778281 | Clinical manifestations, radiographic findings, treatment options, and outcome in sarcoidosis patients with upper respiratory tract involvement. |
| Q45169852 | Clinical outcomes in sarcoidosis after cessation of infliximab treatment |
| Q64459113 | Comparison of Sarcoidosis Phenotypes Among Affected African-American Siblings |
| Q38085774 | Concomitant sarcoidosis and a connective tissue disease: review of the clinical findings and postulations concerning their association. |
| Q24633717 | Current and emerging pharmacological treatments for sarcoidosis: a review |
| Q84603429 | Cutaneous sarcoidosis |
| Q45726271 | Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis |
| Q91948784 | Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline |
| Q53134606 | Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. |
| Q55055046 | Efficacy and safety of apremilast in chronic cutaneous sarcoidosis. |
| Q37649330 | Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations. |
| Q81342193 | Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis |
| Q54330995 | Endoscopic ultrasonography with fine-needle aspiration: an accurate and simple diagnostic modality for sarcoidosis. |
| Q48548647 | Genome-wide search for sarcoidosis susceptibility genes in African Americans |
| Q53163272 | Granulomatosis and polyangitis followed by alveolar proteinosis in a 32-year-old woman. |
| Q48009430 | Health-related quality of life of persons with sarcoidosis |
| Q81025405 | Hepatic, splenic, and gastrointestinal involvement with sarcoidosis |
| Q74597272 | Highly active antiretroviral therapy for HIV with tuberculosis: pardon the granuloma |
| Q44135910 | Impact of systemic corticosteroids on healthcare utilization in patients with sarcoidosis |
| Q35066461 | Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis |
| Q33997625 | Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement |
| Q85012160 | Intracavitary voriconazole for the treatment of hemoptysis complicating Pseudallescheria angusta pulmonary mycetomas in fibrocystic sarcoidosis |
| Q44679010 | Isolated neurosarcoidosis: case series in 2 sarcoidosis centers |
| Q45249355 | Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). |
| Q42706504 | Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis |
| Q35410843 | Mediastinal lymphadenopathy in patients undergoing cardiac transplant evaluation. |
| Q34005197 | Neurological deficits during treatment with tumor necrosis factor-alpha antagonists |
| Q86847144 | Neurosarcoidosis |
| Q33523262 | Neurosarcoidosis: presentations and management |
| Q81024935 | Noninvasive Aspergillus pulmonary disease |
| Q37057112 | Organizing pneumonia. |
| Q38111629 | Patient-reported outcome measures for sleep disorders and related problems: clinical and research applications. |
| Q43188388 | Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study |
| Q73872305 | Pharyngitis, splenomegaly, and hilar and peripheral adenopathy in a 29-year-old man with acute hypoxic respiratory failure |
| Q73793937 | Pleural effusion caused by trapped lung |
| Q51799760 | Pleural effusions in a series of 181 outpatients with sarcoidosis. |
| Q74069187 | Pneumoperitoneum to treat air leaks and spaces after a lung volume reduction operation |
| Q37229708 | Quality of life evaluation in sarcoidosis: current status and future directions. |
| Q92291074 | Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis |
| Q37880590 | Rapid development of sarcoid tenosynovitis. |
| Q46562058 | Reply to: Monogenic early-onset sarcoidosis is no longer a variant of "idiopathic" sarcoidosis |
| Q94444580 | Sarcoidosis |
| Q39504304 | Sarcoidosis in America. Analysis Based on Health Care Use. |
| Q81246628 | Sarcoidosis presenting as bilateral vocal cord paralysis from bilateral compression of the recurrent laryngeal nerves from thoracic adenopathy |
| Q38002998 | Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. |
| Q37057108 | Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. |
| Q83100437 | Sarcoidosis: lost in translation |
| Q80809710 | Sarcoidosis: social predictors of severity at presentation |
| Q92280036 | Screening sarcoidosis patients for cardiac sarcoidosis: What the data really show |
| Q85237693 | Small fiber neuropathy in sarcoidosis: Something beneath the surface |
| Q44073428 | Spinal cord neurosarcoidosis |
| Q37293727 | Staple metalloptysis after lung resection for mycetoma: a case report and a review of the literature. |
| Q82623656 | Successful treatment of lupus pernio with adalimumab |
| Q44061865 | Thalidomide for chronic sarcoidosis |
| Q77926166 | The "fairy ring": a new radiographic finding in sarcoidosis |
| Q38679750 | The Assessment of Cough in a Sarcoidosis Clinic Using a Validated instrument and a Visual Analog Scale. |
| Q51674401 | The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. |
| Q92454981 | The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials |
| Q81420991 | The diagnosis of sarcoidosis |
| Q78952702 | The diagnostic pathway to sarcoidosis |
| Q35660312 | The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis |
| Q91275597 | The epidemic of drug-induced sarcoidosis-like reactions: a side effect that we can live with |
| Q73644594 | The etiologic agent of sarcoidosis: what if there isn't one? |
| Q80233363 | The management of sarcoidosis by the primary care physician |
| Q54409042 | The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial. |
| Q38791753 | The three tiers of screening for sarcoidosis organ involvement |
| Q34597528 | The treatment of lupus pernio: results of 116 treatment courses in 54 patients. |
| Q34267473 | The treatment of pulmonary sarcoidosis. |
| Q46460401 | The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis |
| Q81509113 | Tissue verification of stage I sarcoidosis: the question is if, not how |
| Q49163751 | Treatment of a solitary pulmonary sarcoidosis mass by CT-guided direct intralesional injection of corticosteroid |
| Q44647055 | Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen |
| Q46375478 | Treatment of sarcoidosis with infliximab |
| Q79135460 | Trouble below the surface |
| Q48352590 | Tuberculous mediastinal lymphadenitis that evolved into pulmonary tuberculosis following transbronchial needle aspiration |
| Q79849970 | Unusual presentations of pulmonary sarcoidosis: cases from the medical university of South Carolina |
| Q82787787 | Vaginal involvement in a patient with sarcoidosis |
| Q36823331 | Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature. |
Search more.